Page last updated: 2024-09-03

1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine and fluvoxamine

1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine has been researched along with fluvoxamine in 1 studies

Compound Research Comparison

Studies
(1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine)
Trials
(1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine)
Recent Studies (post-2010)
(1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine)
Studies
(fluvoxamine)
Trials
(fluvoxamine)
Recent Studies (post-2010) (fluvoxamine)
14102,051518434

Protein Interaction Comparison

ProteinTaxonomy1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine (IC50)fluvoxamine (IC50)
DRattus norvegicus (Norway rat)0.54
D(3) dopamine receptorRattus norvegicus (Norway rat)0.54
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.54
D(4) dopamine receptorRattus norvegicus (Norway rat)0.54
Sodium-dependent serotonin transporterHomo sapiens (human)0.0038
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.54
D(2) dopamine receptorRattus norvegicus (Norway rat)0.54
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)3.1
TransporterRattus norvegicus (Norway rat)0.54

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bubl, B; Feuerstein, TJ; Hubbe, U; Huethe, F; Jackisch, R; Löffler, M; McIntosh, JM1

Other Studies

1 other study(ies) available for 1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine and fluvoxamine

ArticleYear
Dopamine release in human neocortical slices: characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release.
    Brain research bulletin, 2006, Jan-30, Volume: 68, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adolescent; Adult; Aged; Alkaloids; Analysis of Variance; Animals; Autoreceptors; Azocines; Calcium; Child; Child, Preschool; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Feedback; Female; Fluvoxamine; Humans; In Vitro Techniques; Isoxazoles; Male; Maprotiline; Mice; Middle Aged; Neocortex; Nicotine; Nicotinic Antagonists; Potassium; Pyrrolidines; Quinolizines; Rats; Receptors, Nicotinic; Sulpiride; Time Factors; Tritium

2006